Autoimmune Disease Therapeutics - Global Market Outlook (2015-2022)

Autoimmune Disease Therapeutics - Global Market Outlook (2015-2022)

  • Published: March 2016
  • ID: SMRC15619

According to Stratistics MRC, the Global Autoimmune Disease Therapeutics Market is accounted for $51.2 billion in 2015 and is expected to reach $82.13 billion by 2022 growing at a CAGR of 6.9% during the forecast period. Rising healthcare expenditure in the region is one of the key factors fueling the market growth. On the other hand, insufficient funding in emerging countries and high cost involved in the treatment of the disease are hindering the market. Biologics drug acts as initial line of treatment due to therapeutic capabilities in controlling and treatment of different autoimmune complications.

North America is the largest market for autoimmune disease therapeutics due to increasing incidence of different forms of autoimmune disorders, and government initiatives in the region. Europe is expected to be the second largest market due to rising healthcare infrastructure and penetration of new technologies.

Some of the key players in the market include Johnson & Johnson Inc, Bayer Schering Pharma AG, Elan Corporation Plc, Abbott Laboratories, Genentech Inc, GlaxoSmithKline Plc, Bristol-Myers Squibb, Chugai Pharmaceutical Co. Ltd., Merck & Co. Inc, Amgen Inc, Eli Lilly and Company, F. Hoffmann-La Roche AG, Biogen Idec Inc, Teva Pharmaceuticals, Industries Limited, UCB S.A., Sanofi-Aventis SA, Novartis AG and Shire Plc.

Distribution Channel:
• Drug Stores
• Hospitals
• Independent Pharmacies
• Clinics

Drug Class Covered:
• Anti-Inflammatory Drugs
• Biologics
• Immunosuppressant’s
• Nonsteroidal anti-inflammatory drugs
• Corticosteroids

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain
o Rest of Europe      
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil      
o Argentina       
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary
   
2 Preface 

 2.1 Abstract
 2.2 Stake Holders
 2.3 Research Scope
 2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
 2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions
   
3 Market Trend Analysis
 3.1 Introduction
 3.2 Drivers 
 3.3 Restraints
 3.4 Opportunities
 3.5 Threats 
 3.6 Emerging Markets
   
4 Porters Five Force Analysis

 4.1 Bargaining power of suppliers
 4.2 Bargaining power of buyers
 4.3 Threat of substitutes
 4.4 Threat of new entrants
 4.5 Competitive rivalry
   
5 Global Autoimmune Disease Therapeutics Market, By Distribution Channel
 5.1 Introduction 
 5.2 Drug Stores
 5.3 Hospitals
 5.4 Independent Pharmacies
 5.5 Clinics 
   
6 Global Autoimmune Disease Therapeutics Market, By Drug Class
 6.1 Introduction 
 6.2 Anti-Inflammatory Drugs
 6.3 Biologics
 6.4 Immunosuppressant’s
 6.5 Nonsteroidal anti-inflammatory drugs
 6.6 Corticosteroids
   
7 Global Autoimmune Disease Therapeutics Market, By Geography
 7.1 North America
  7.1.1 US
  7.1.2 Canada
  7.1.3 Mexico
 7.2 Europe 
  7.2.1 Germany
  7.2.2 France
  7.2.3 Italy
  7.2.4 UK
  7.2.5 Spain
  7.2.6 Rest of Europe
 7.3 Asia Pacific
  7.3.1 Japan
  7.3.2 China
  7.3.3 India
  7.3.4 Australia
  7.3.5 New Zealand
  7.3.6 Rest of Asia Pacific
 7.4 Rest of the World
  7.4.1 Middle East
  7.4.2 Brazil
  7.4.3 Argentina
  7.4.4 South Africa
  7.4.5 Egypt
   
8 Key Developments
 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
 8.2 Acquisitions & Mergers
 8.3 New Product Launch
 8.4 Expansions
 8.5 Other Key Strategies
   
9 Company Profiling
9.1 Johnson & Johnson Inc
9.2 Bayer Schering Pharma AG
9.3 Elan Corporation Plc
9.4 Abbott Laboratories
9.5 Genentech Inc
9.6 GlaxoSmithKline Plc
9.7 Bristol-Myers Squibb 
9.8 Chugai Pharmaceutical Co. Ltd.
9.9 Merck & Co. Inc
9.10 Amgen Inc
9.11 Eli Lilly and Company
9.12 F. Hoffmann-La Roche AG
9.13 Biogen Idec Inc
9.14 Teva Pharmaceuticals Industries Limited
9.15 UCB S.A.
9.16 Sanofi-Aventis SA
9.17 Novartis AG
9.18 Shire Plc


List of Tables 
1 Global Autoimmune Disease Therapeutics Market Outlook, By Region (2013-2022) ($MN)
2 Global Autoimmune Disease Therapeutics Market Outlook, By Distribution Channel (2013-2022) ($MN)
3 Global Autoimmune Disease Therapeutics Market Outlook, By Drug Stores (2013-2022) ($MN)
4 Global Autoimmune Disease Therapeutics Market Outlook, By Hospitals (2013-2022) ($MN)
5 Global Autoimmune Disease Therapeutics Market Outlook, By Independent Pharmacies (2013-2022) ($MN)
6 Global Autoimmune Disease Therapeutics Market Outlook, By Clinics (2013-2022) ($MN)
7 Global Autoimmune Disease Therapeutics Market Outlook, By Drug Class (2013-2022) ($MN)
8 Global Autoimmune Disease Therapeutics Market Outlook, By Anti-Inflammatory Drugs (2013-2022) ($MN)
9 Global Autoimmune Disease Therapeutics Market Outlook, By Biologics (2013-2022) ($MN)
10 Global Autoimmune Disease Therapeutics Market Outlook, By Immunosuppressant’s (2013-2022) ($MN)
11 Global Autoimmune Disease Therapeutics Market Outlook, By Nonsteroidal anti-inflammatory drugs (2013-2022) ($MN)
12 Global Autoimmune Disease Therapeutics Market Outlook, By Corticosteroids (2013-2022) ($MN)
13 North America Autoimmune Disease Therapeutics Market Outlook, By Distribution Channel (2013-2022) ($MN)
14 North America Autoimmune Disease Therapeutics Market Outlook, By Drug Stores (2013-2022) ($MN)
15 North America Autoimmune Disease Therapeutics Market Outlook, By Hospitals (2013-2022) ($MN)
16 North America Autoimmune Disease Therapeutics Market Outlook, By Independent Pharmacies (2013-2022) ($MN)
17 North America Autoimmune Disease Therapeutics Market Outlook, By Clinics (2013-2022) ($MN)
18 North America Autoimmune Disease Therapeutics Market Outlook, By Drug Class (2013-2022) ($MN)
19 North America Autoimmune Disease Therapeutics Market Outlook, By Anti-Inflammatory Drugs (2013-2022) ($MN)
20 North America Autoimmune Disease Therapeutics Market Outlook, By Biologics (2013-2022) ($MN)
21 North America Autoimmune Disease Therapeutics Market Outlook, By Immunosuppressant’s (2013-2022) ($MN)
22 North America Autoimmune Disease Therapeutics Market Outlook, By Nonsteroidal anti-inflammatory drugs (2013-2022) ($MN)
23 North America Autoimmune Disease Therapeutics Market Outlook, By Corticosteroids (2013-2022) ($MN)
24 Europe Autoimmune Disease Therapeutics Market Outlook, By Distribution Channel (2013-2022) ($MN)
25 Europe Autoimmune Disease Therapeutics Market Outlook, By Drug Stores (2013-2022) ($MN)
26 Europe Autoimmune Disease Therapeutics Market Outlook, By Hospitals (2013-2022) ($MN)
27 Europe Autoimmune Disease Therapeutics Market Outlook, By Independent Pharmacies (2013-2022) ($MN)
28 Europe Autoimmune Disease Therapeutics Market Outlook, By Clinics (2013-2022) ($MN)
29 Europe Autoimmune Disease Therapeutics Market Outlook, By Drug Class (2013-2022) ($MN)
30 Europe Autoimmune Disease Therapeutics Market Outlook, By Anti-Inflammatory Drugs (2013-2022) ($MN)
31 Europe Autoimmune Disease Therapeutics Market Outlook, By Biologics (2013-2022) ($MN)
32 Europe Autoimmune Disease Therapeutics Market Outlook, By Immunosuppressant’s (2013-2022) ($MN)
33 Europe Autoimmune Disease Therapeutics Market Outlook, By Nonsteroidal anti-inflammatory drugs (2013-2022) ($MN)
34 Europe Autoimmune Disease Therapeutics Market Outlook, By Corticosteroids (2013-2022) ($MN)
35 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Distribution Channel (2013-2022) ($MN)
36 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Drug Stores (2013-2022) ($MN)
37 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Hospitals (2013-2022) ($MN)
38 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Independent Pharmacies (2013-2022) ($MN)
39 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Clinics (2013-2022) ($MN)
40 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Drug Class (2013-2022) ($MN)
41 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Anti-Inflammatory Drugs (2013-2022) ($MN)
42 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Biologics (2013-2022) ($MN)
43 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Immunosuppressant’s (2013-2022) ($MN)
44 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Nonsteroidal anti-inflammatory drugs (2013-2022) ($MN)
45 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Corticosteroids (2013-2022) ($MN)
46 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Distribution Channel (2013-2022) ($MN)
47 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Drug Stores (2013-2022) ($MN)
48 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Hospitals (2013-2022) ($MN)
49 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Independent Pharmacies (2013-2022) ($MN)
50 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Clinics (2013-2022) ($MN)
51 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Drug Class (2013-2022) ($MN)
52 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Anti-Inflammatory Drugs (2013-2022) ($MN)
53 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Biologics (2013-2022) ($MN)
54 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Immunosuppressant’s (2013-2022) ($MN)
55 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Nonsteroidal anti-inflammatory drugs (2013-2022) ($MN)
56 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Corticosteroids (2013-2022) ($MN)

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials